Search this blog:    Health  Society  Women



Study Reveals Alarming Gaps in HER2 Therapy Access for Patients With Breast Cancer

Despite increasing use of HER2-targeting breast cancer therapies, uptake of these agents persists, according to findings from a retrospective cohort study. The authors reported that only about 75% of all hormone receptor-negative (HR–)/HER2-positive ...


View article...


Top stories of the last 30 days